Healthcare / Robotic SurgeryTechnical Analysis Guide

ISRG Stock Analysis

Intuitive Surgical, Inc.

💡 Quick Answer

Across 4 APEX technical signals, ISRG is currently split between bullish and bearish readings — 0 bullish, 0 bearish as of 2026-07-08. Run a live analysis to see the current composite score.

ISRG is a premium growth compounder with elevated ATR (4-6%) reflecting its high valuation multiple. Procedure volume growth.

Procedure Volume: Monthly tracking possibleRSI Behavior: Premium growth 50-80 rangeda Vinci 5 Adoption: Capital cycle catalyst

Intuitive Surgical invented the robotic surgery market with the da Vinci surgical system and holds dominant market share in soft tissue robotic procedures. Gynecology, urology, colorectal surgery, and thoracic surgery. Its razor-and-blade model generates highly recurring revenue: hospitals pay for the robot (capital), then ISRG collects per-procedure instrument fees for the life of each system. The next-generation da Vinci 5 system, launched in 2024, adds force feedback and AI-guided surgical assistance.

LIVE CHART·ISRG. DailyPowered by TradingView

Open ISRG on TradingView ↗Affiliate link

Get live ISRG signal analysis

APEX runs 8 signals on ISRG in real time: RSI, MACD, Fibonacci, Volume, and more.

Analyze ISRG Now →

Why Do Traders Watch ISRG?

ISRG is a premium growth compounder with elevated ATR (4-6%) reflecting its high valuation multiple. Procedure volume growth. Disclosed monthly by tracking hospital data and quarterly in earnings. Is the primary stock driver. Post-earnings moves of 8-12% are common and strongly directional: beat with raised guidance produces sustained multi-week moves. ISRG is relatively immune to drug pricing and insurance policy risk.

Is ISRG a Buy Right Now? Current Signal Readings

📦Procedure VolumeMonthly tracking possible

ISRG's global da Vinci procedure volume is the single most important metric. It drives instrument revenue (recurring), system utilization, and future capital equipment decisions. Procedure growth above 15% year-over-year has historically produced 10-15% positive earnings reactions. Hospital survey data provides 30-45 day advance signals.

📊RSI BehaviorPremium growth 50-80 range

ISRG commands a premium valuation that translates to an elevated RSI range. In strong markets, RSI sustains above 60 for quarters at a time. RSI dips to 48-52 during broad healthcare selloffs. While procedure growth remains intact. Have been the most reliable ISRG entry zones for 3-6 month holds.

📊da Vinci 5 AdoptionCapital cycle catalyst

The da Vinci 5 launch represents a hospital capital replacement cycle. Hospitals with older da Vinci Xi systems are upgrading, generating capital equipment revenue above analyst models. Each quarter of da Vinci 5 placements above consensus expectations drives ASP (average selling price) expansion and subsequent instrument attach-rate growth.

📊Fibonacci38.2% retracement key level

ISRG's corrections during bull markets typically find support at the 38.2% Fibonacci retracement. Shallower than most stocks because of its consistent earnings beats and defensive institutional base. The stock rarely reaches the 61.8% level without a fundamental deterioration in procedure volumes.

📋 ISRG Key Stats for Traders

⚡ATR (14-day)4-6% of price

📦Avg daily volume~1-2 million shares

🎯Key metricProcedure volume growth YoY

📅Post-earnings move8-12% typical

🔗 Related Stocks

SYK MDT ABT BSX

Run a live ISRG analysis

APEX combines RSI, MACD, Fibonacci, Volume, and 4 more signals into one composite score in under 30 seconds.

Analyze ISRG Free →

Advanced charting for ISRG on TradingView ↗

💬 Frequently Asked Questions. ISRG

QIs ISRG a good stock to buy right now?

AWhether ISRG is a buy depends on its current technical positioning. ISRG is a premium growth compounder with elevated ATR (4-6%) reflecting its high valuation multiple. Procedure volume growth. Disclosed monthly by tracking hospital data and quarterly in earnings. Is the primary stock driver. Post-earnings moves of 8-12% are common and strongly directional: beat with raised guidance produces sustained multi-week moves. ISRG is relatively immune to drug pricing and insurance policy risk. Run a live APEX analysis at apexstockintel.com to see the current composite score, RSI, and MACD signals. Updated every trading day.

QWhat are the most important technical signals for ISRG?

AThe four key signals for ISRG are: Procedure Volume (Monthly tracking possible). ISRG's global da Vinci procedure volume is the single most important metric. It drives instrument revenue (recurring), system utilization, and future capital equipment decisions. Procedure growth above 15% year-over-year has historically produced 10-15% positive earnings reactions. Hospital survey data provides 30-45 day advance signals.. RSI Behavior (Premium growth 50-80 range). ISRG commands a premium valuation that translates to an elevated RSI range. In strong markets, RSI sustains above 60 for quarters at a time. RSI dips to 48-52 during broad healthcare selloffs. While procedure growth remains intact. Have been the most reliable ISRG entry zones for 3-6 month holds.. da Vinci 5 Adoption (Capital cycle catalyst). The da Vinci 5 launch represents a hospital capital replacement cycle. Hospitals with older da Vinci Xi systems are upgrading, generating capital equipment revenue above analyst models. Each quarter of da Vinci 5 placements above consensus expectations drives ASP (average selling price) expansion and subsequent instrument attach-rate growth.. Fibonacci (38.2% retracement key level). ISRG's corrections during bull markets typically find support at the 38.2% Fibonacci retracement. Shallower than most stocks because of its consistent earnings beats and defensive institutional base. The stock rarely reaches the 61.8% level without a fundamental deterioration in procedure volumes.

QWhat is ISRG's RSI telling traders right now?

AISRG commands a premium valuation that translates to an elevated RSI range. In strong markets, RSI sustains above 60 for quarters at a time. RSI dips to 48-52 during broad healthcare selloffs. While procedure growth remains intact. Have been the most reliable ISRG entry zones for 3-6 month holds. APEX scores ISRG's RSI as part of its 8-factor composite signal. Updated daily.

QHow does ISRG behave technically compared to other Healthcare / Robotic Surgery stocks?

AISRG is in the Healthcare / Robotic Surgery sector. Intuitive Surgical invented the robotic surgery market with the da Vinci surgical system and holds dominant market share in soft tissue robotic procedures. Gynecology, urology, colorectal surgery, and thoracic surgery. Its razor-and-blade model generates highly recurring revenue: hospitals pay for the robot (capital), then ISRG collects per-procedure instrument fees for the life of each system. The next-generation da Vinci 5 system, launched in 2024, adds force feedback and AI-guided surgical assistance. Key stats: ATR (14-day): 4-6% of price, Avg daily volume: ~1-2 million shares, Key metric: Procedure volume growth YoY, Post-earnings move: 8-12% typical.

QWhat MACD signals work best for ISRG?

AMACD measures momentum direction via the relationship between two exponential moving averages. Bullish crossovers (MACD line crossing above the signal line) indicate increasing upward momentum, while bearish crossovers signal the opposite. APEX tracks ISRG's MACD histogram direction daily.

OTHER STOCK GUIDES

Technology49

+−